Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasms by Site × abiraterone × Clear all

Sponsor

Conditions

Prostatic Neoplasms 24 Neoplasm Metastasis 2 Carcinoma, Non-Small-Cell Lung 2 Urogenital Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumours 1 Small Cell Lung Carcinoma 1 Prostatic Neoplasms, Castration-Resistant 1 Primary Myelofibrosis 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Newly Diagnosed Oligometastatic Prostate Cancer 1 Neoplasms 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Metastatic Castration-resistant Prostate Cancer 1 Metastatic Castration-Resistant Prostate Cancer 1 Metastatic Castration Resistant Prostate Cancer 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Leukemia 1 Glioblastoma 1 Colorectal Neoplasms 1 Carcinoma, Small Cell 1 Breast Neoplasms 1 Anus Neoplasms 1

Interventions

Gemcitabine 4 130-nm albumin-bound paclitaxel 4 pembrolizumab 3 napabucasin 3 Paclitaxel 3 Irinotecan 3 selpercatinib 2 pralsetinib 2 patritumab 2 Standard of Care 2 Pemetrexed 2 Nivolumab 2 Fluorouracil 2 Cyclophosphamide 2 Cisplatin 2 Carboplatin 2 Ascorbic Acid 2 Albumin-Bound Paclitaxel 2 valrubicin 1 sotorasib 1 ribociclib 1 relatlimab 1 pamiparib 1 osimertinib 1 ipatasertib 1 durvalumab 1 dostarlimab 1 cobimetinib 1 atezolizumab 1 alectinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡